Tech World Herald - Active Pharmaceutical Ingredient Market Sustain With CAGR Of 6.4% By 2026

Active Pharmaceutical Ingredient Market Sustain With CAGR Of 6.4% By 2026

Newsdesk 11/7 12:01

Active Pharmaceutical Ingredients (API) is commonly referred as ?Drug substance? or ?Bulk pharmaceutical chemical?. Active ingredient is the substance which is biologically active in pharmaceutical drug. Active Pharmaceutical Ingredients (API) of good quality are core to the manufacturing of effective and safe essential drugs. Initially only limited number of large manufacturers of finished pharmaceutical products have their own API manufacturing plants.

The first five-year cumulative revenue (2018?2023) is projected to be over US$ 9.0 Bn, which is expected to increase considerably over the latter part of the five-year forecast period. The global active pharmaceutical ingredient market is projected to value at approximately US$ 1.5 Bn in 2019, and is expected to register a CAGR of over 6.4%.

An increasing number of FDA approvals regarding new molecular entities, many large-scale manufacturers and providers are focusing on better API production, most of the key generic drug manufacturing firms have their captive API manufacturing facility are this is a trend that witnessed in the global market. Furthermore, the expiration of patents for branded highly prescribed drugs will continue to impact health care spending as many lower-cost generics are now entering to participate in the pharmaceutical market and lower down the costs.

Technological innovation and advancements in recent few years for API?s manufacturing process and equipment have allowed more prompt and rapid treatment done by healthcare providers.

Global Active Pharmaceutical Ingredient Market: Market Forecast

The comprehensive research report comprises a complete forecast of the global Active Pharmaceutical Ingredient market based on factors affecting the market and their impact in the foreseeable future. According to the forecast projections, revenue from the global Active Pharmaceutical Ingredient market is expected to expand at a CAGR of 6.4% over the forecast period.

Global Active Pharmaceutical Ingredient Market: Segmental Snapshot

By Manufacturing Process: The captive manufacturing segment accounted for highest revenue share contribution as compared to other segment. The contract manufacturing segment is expected to register a CAGR of over 6.4% between 2018 and 2028.

By API Type: The synthetic API segment accounted for highest revenue share contribution as compared to other API type segment. The biological API segment is expected to register a CAGR of over 6.8% between 2018 and 2028.

By Drug Type: The prescription drugs segment accounted for highest revenue share contribution as compared to other drug type segment, and is expected to register a CAGR of over 6.3% between 2018 and 2028.

By Therapeutic Area: The cardiovascular diseases segment accounted for highest revenue share contribution as compared to other therapeutic area segment. The oncology segment is expected to register a CAGR of over 6.9% between 2018 and 2028.

By Region: The market in Asia Pacific accounted for highest revenue share in the global Active Pharmaceutical Ingredient market in 2019, and is expected to register a CAGR of over 6.6% between 2018 and 2028.

Request For Sample Report Before Buying

Global Active Pharmaceutical Ingredient Market: Competitive Analysis

The research report on the global active pharmaceutical ingredient market include profiles of some of major companies such Teva Pharmaceutical Industries Ltd., Merck & Co., Mylan N.V., Sanofi, Ipca Laboratories Ltd., Aurobindo Pharma, Cipla Limited, Lupin Limited, GlaxoSmithKline plc, and Novartis Pharmaceuticals Corporation.


Pressmeddelandet skickades med Mynewsdesk

Till pressmeddelandet

Teckenstorlek

Tipsa

Blogga

Skriv ut




LÅNEFÖREMEDLARE:



ALLA LÅN:




- låna pengar snabbt?
- lån utan uc?
- lån med betalningsanmärkning?

Beställ årsredovisningar gratis!

Ekonomi Nyheter .se - Innehåll

 

 

 

 

DMCA.com Protection Status